Paul Tudor Jones Bio Techne Corp Transaction History

Tudor Investment Corp Et Al

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$65.98 - $77.09 $1.2 Million - $1.4 Million	18,183 New	18,183 $1.28 Million
Q1 2023 May 15, 2023	BUY	$71.62 - $86.62 $6.13 Million - $7.41 Million	85,574 Added 108.75%	164,262 $12.2 Million
Q4 2022 Feb 14, 2023	BUY	$80.67 - $352.29 $4.77 Million - $20.8 Million	59,153 Added 302.81%	78,688 $6.52 Million
Q3 2022 Nov 14, 2022	BUY	$282.54 - $391.85 $3.21 Million - $4.45 Million	11,352 Added 138.73%	19,535 $5.55 Million
Q2 2022 Aug 15, 2022	BUY	$322.67 - $449.65 $1.57 Million - $2.19 Million	4,866 Added 146.7%	8,183 $2.84 Million
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $976,509 - $1.14 Million	2,521 Added 316.71%	3,317 $1.49 Million
Q1 2021 May 17, 2021	SELL	$314.62 - $411.0 $940,399 - $1.23 Million	-2,989 Reduced 78.97%	796 $304,000
Q4 2020 Feb 16, 2021	SELL	$246.9 - $321.87 $558,240 - $727,748	-2,261 Reduced 37.4%	3,785 $1.2 Million
Q3 2020 Nov 16, 2020	BUY	$232.22 - $282.96 $1.4 Million - $1.71 Million	6,046 New	6,046 $1.5 Million
Q2 2020 Aug 14, 2020	SELL	$185.43 - $279.56 $969,428 - $1.46 Million	-5,228 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$161.17 - $221.51 $544,593 - $748,482	3,379 Added 182.75%	5,228 $991,000
Q4 2019 Feb 14, 2020	BUY	$189.68 - $222.09 $350,718 - $410,644	1,849 New	1,849 $406,000
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $1.18 Million - $1.39 Million	-6,403 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $1.21 Million - $1.38 Million	6,403 New	6,403 $1.34 Million

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.